業績 Performance

論文

海外誌

  • Tomohisa Nakamura*, Tadahiro Hashita*, Yuxin Chen, Yuan Gao, Yang Sun, Sadequl Islam, Hiroyuki Sato, Yasuyuki Shibuya, Kun Zou, Tamihide Matsunaga, Makoto Michikawa.
    Aβ42 treatment of the brain side reduced the level of flotillin from endothelial cells on the blood side via FGF-2 signaling in a blood-brain barrier model.
    Molecular Brain. In press, 2023. *Co-first author
  • Hiromasa Aoki, Misaki Yamashita, Tadahiro Hashita, Takahiro Iwao, Mineyoshi Aoyama, Tamihide Matsunaga.
    Generation of Brain Microvascular Endothelial-like Cells from Human iPS Cell-Derived Endothelial Progenitor Cells Using TGF-β Receptor Inhibitor, Laminin 511 Fragment, and Neuronal Cell Culture Supplements.
    Pharmaceutics. 14(12);2697:2023.
  • Anna Nakanishi, Hiroki Okumura, Tadahiro Hashita, Aya Yamashita, Yuka Nishimura, Chihiro Watanabe, Sakina Kamimura, Sanae Hayashi, Shuko Murakami, Kyoko Ito, Takahiro Iwao, Akari Ikeda, Tomoyasu Hirose, Toshiaki Sunazuka, Yasuhito Tanaka, Tamihide Matsunaga.
    Ivermectin inhibits HBV entry into the nucleus by suppressing KPNA2.
    Viruses. 14(11);2468:2023.

総説・著書・総合論文

  • 松永民秀, 坡下真大, 岩尾岳洋.
    「真の実臨床応用をめざした再生医療2023 リバーストランスレーションリサーチのいまと産業化のための技術開発」
    実験医学増刊, 41 (2);134-138:2023.

新聞掲載

  • 中日新聞  2023年1月5日
    薬のシート 分別し再生